midazolam has been researched along with Drowning in 1 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Drowning: Death that occurs as a result of anoxia or heart arrest, associated with immersion in liquid.
| Excerpt | Relevance | Reference |
|---|---|---|
| " He had received therapeutic dosing of phenobarbital and midazolam up to 5 hours prior to a brain death examination." | 1.35 | A 10-month-old infant with reversible findings of brain death. ( deCaen, AR; Duff, J; Joffe, AR; Kolski, H, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joffe, AR | 1 |
| Kolski, H | 1 |
| Duff, J | 1 |
| deCaen, AR | 1 |
1 other study available for midazolam and Drowning
| Article | Year |
|---|---|
A 10-month-old infant with reversible findings of brain death.
Topics: Brain; Brain Death; Drowning; Electroencephalography; Excitatory Amino Acid Antagonists; GABA Modula | 2009 |